Patent · US Active

Zika virus purification

US11524064B2 · kind B2 · utility

5Cited by

8References

18Claims

0Family size

Assignee

Valneva Austria GmbH · AT

Inventors

Jana Barbero Calzado · Wien, AT
Mario Nebenführ · Wien, AT
Robert Schiegl · Siegenfeld, AT
Michael Weber · Wien, AT
Jürgen Heindl-Wruss · Wien, AT

Key dates

Filing date	Jul 13, 2020
Grant date	Dec 13, 2022
Priority date	—
Expiry date	Jul 13, 2040

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are processes for purifying infectious Zika virus particles and uses of protamine in such processes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.